Pfizer allows 95 nations to make its COVID-19 pill, 53% of world's population likely to benefit
Published
Pfizer's clinical trials suggest COVID-19 pill cuts the risk of hospitalisation or death by 89% in non-hospitalised high-risk adults with coronavirus.
Full Article